Lytix Biopharma AS

NEW
OSL:LYTIX (Norway)   Ordinary Shares
kr 7.5 (0%) Aug 21
At Loss
P/B:
5.04
Market Cap:
kr 576.75M ($ 61.99M)
Enterprise V:
kr 458.59M ($ 49.29M)
Volume:
10.64K
Avg Vol (2M):
33.23K
Trade In:
Volume:
10.64K
At Loss
Avg Vol (2M):
33.23K

Lytix Biopharma AS (OSL:LYTIX) Dividend

Lytix Biopharma AS (OSL:LYTIX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -19.4%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: OSL:LYTIX Dividend

Does Lytix Biopharma AS (OSL:LYTIX) pay a dividend?

Lytix Biopharma AS (OSL:LYTIX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Lytix Biopharma AS pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Lytix Biopharma AS has returned capital to shareholders via buybacks at a rate of -19.4% over the past 3 years.

What are dividend-paying alternatives to Lytix Biopharma AS?

For dividend-paying alternatives in Lytix Biopharma AS's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.